CVE-2009-3263

Public Exploit

Description

Cross-site scripting (XSS) vulnerability in Google Chrome 2.x and 3.x before 3.0.195.21 allows remote attackers to inject arbitrary web script or HTML via a (1) RSS or (2) Atom feed, related to the rendering of the application/rss+xml content type as XML "active content."

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.39%
Vendor Advisory blogspot.com Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/archive/1/506517/100/0/threaded mailing list
http://securethoughts.com/2009/09/exploiting-chrome-and-operas-inbuilt-atomrss-reader-with-script-execution-and-more/ exploit
http://www.securityfocus.com/bid/36416 vdb entry
http://googlechromereleases.blogspot.com/2009/09/stable-channel-update.html vendor advisory
http://code.google.com/p/chromium/issues/detail?id=21238
http://secunia.com/advisories/36770 third party advisory vendor advisory

Frequently Asked Questions

What is the severity of CVE-2009-3263?
CVE-2009-3263 has been scored as a medium severity vulnerability.
How to fix CVE-2009-3263?
To fix CVE-2009-3263, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2009-3263 being actively exploited in the wild?
It is possible that CVE-2009-3263 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.